Somewhat, but these drugs are different from each other.
Both Zeposia and ocrezulimab (Ocrevus) are used in adults to treat:
clinically isolated syndrome (CIS), which may or may not be the first sign of multiple sclerosis (MS)
relapsing-remitting MS (RRMS)
active secondary progressive MS (SPMS)
Ocrevus is also approved to treat adults with primary progressive MS (PPMS). Zeposia can also be used to treat ulcerative colitis (UC), which Ocrevus is not approved to treat.
Although these medications can be used for some of the same conditions, Zeposia and Ocrevus are very different drugs.
Zeposia is a capsule that you take by mouth once daily. In comparison, Ocrevus is a solution that’s injected into a vein every 6 months. These medications work in different ways to treat MS, so they may cause some different side effects.
If you’re interested in learning more about how Zeposia and Ocrevus compare, talk with your doctor. They can help determine what the best treatment option may be for your condition.